SEC Form 4 · accession 0001209191-17-010659
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L Lubniewski
Officer — Chief Business Officer
Period of report
Feb 13, 2017
Accepted (ET)
Feb 14, 2017 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.92 | Feb 13, 2017 | A | 20,000 | A | — | Feb 12, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1One-hundred percent (100%) of the shares vest on the one-year anniversary of the grant date.